Craig A. Johnson - 21 Jun 2021 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/ Lisa Peraza Attorney-in-fact for Craig A. Johnson
Issuer symbol
HRTX
Transactions as of
21 Jun 2021
Net transactions value
-$3,801
Form type
4
Filing time
22 Jun 2021, 17:05:20 UTC
Next filing
23 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Sale $3,801 -250 -7% $15.20 3,340 21 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 3, 2021.
F2 The range of sales prices received was $14.89 to $15.42. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.